Zobrazeno 1 - 10
of 532
pro vyhledávání: '"Lin, Lin"'
Autor:
Feixue Wang, Wei Wang, Peng Yin, Yunning Liu, Jiangmei Liu, Lijun Wang, Jinlei Qi, Jinlin You, Lin Lin, Maigeng Zhou
Publikováno v:
Journal of Diabetes Research. 2022:1-11
Objectives. To analyze diabetes mellitus (DM) mortality and years of life lost (YLL) in different years and different subgroups at the national and regional levels in China from 2005 to 2020. Methods. We estimated mortality and YLL of DM and its subc
Autor:
Lin Lin, Pugui Li, Xin Liu, Xiuyuan Xie, Liping Liu, Anjani Kumar Singh, Himanshu Narayan Singh
Publikováno v:
Systematic Reviews
Systematic Reviews, BioMed Central, 2022, 11 (1), pp.60. ⟨10.1186/s13643-022-01914-7⟩
Systematic Reviews, BioMed Central, 2022, 11 (1), pp.60. ⟨10.1186/s13643-022-01914-7⟩
Background Benign prostate hyperplasia (BPH) is the most common urological problem in elderly males. Recent studies have reported polymorphism in various metabolic genes in BPH. However, their association with the susceptibility of BPH is still incon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71b8de938d2bca9ab63ba313f0f52dd1
https://hal-amu.archives-ouvertes.fr/hal-03831907/file/s13643-022-01914-7.pdf
https://hal-amu.archives-ouvertes.fr/hal-03831907/file/s13643-022-01914-7.pdf
Autor:
Xiao Tong, Kenneth G. Kowalski, Lin Lin, Raj Rajagovindan, Ivan Nestorov, Samantha Budd Haberlain, Kumar Kandadi Muralidharan
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology
CPT: Pharmacometrics & Systems Pharmacology, Vol 11, Iss 1, Pp 7-19 (2022)
CPT: Pharmacometrics & Systems Pharmacology, Vol 11, Iss 1, Pp 7-19 (2022)
Aducanumab is a human immunoglobulin G1 anti‐amyloid beta (Aβ) antibody currently being evaluated for potential treatment of patients with early Alzheimer’s disease. This paper describes the relationship between the population pharmacokinetics (
Autor:
Yi Zhang, Chao Liu, Mian Li, Tianshu Zeng, Min Xu, Ruying Hu, Jiajun Zhao, Huacong Deng, Zhengnan Gao, Yiming Mu, Tao Yang, Qin Wan, Shuangyuan Wang, Yanan Huo, Zhen Ye, Tiange Wang, Zhiyun Zhao, Chunyan Hu, Feixia Shen, Zuojie Luo, Jie Zhang, Li Chen, Yu Xu, Youmin Wang, Qing Su, Guixia Wang, Yufang Bi, Yuhong Chen, Yinfei Zhang, Xulei Tang, Yingfen Qin, Qiang Li, Weiqing Wang, Xuefeng Yu, Li Yan, Lulu Chen, Rui Du, Guijun Qin, Jieli Lu, Gang Chen, Lixin Shi, Lin Lin, Hongyan Qi, Yuanyue Zhu, Guang Ning, Shengli Wu
Publikováno v:
Journal of Diabetes. 13:949-959
Gestational hyperglycemia increases the risk of diabetes in later life. However, the risk of future cardiovascular diseases (CVD) related to gestational hyperglycemia remains inconclusive. The purpose of this study was to investigate the impact of ge
Autor:
Jun Liu, Dan-Dan Li, Wei Dong, Yu-Qi Liu, Yang Wu, Da-Xuan Tang, Fu-Chun Zhang, Meng Qiu, Qi Hua, Jing-Yu He, Jun Li, Bai Du, Ting-Hai Du, Lin-Lin Niu, Xue-Jun Jiang, Bo Cui, Jiang-Bin Chen, Yang-Gan Wang, Hai-Rong Wang, Qin Yu, Jing He, Yi-Lin Mao, Xiao-Fang Bin, Yue Deng, Yu-Dan Tian, Qing-Hua Han, Da-Jin Liu, Li-Qin Duan, Ming-Jun Zhao, Cui-Ying Zhang, Hai-Ying Dai, Ze-Hua Li, Ying Xiao, You-Zhi Hu, Xiao-Yu Huang, Kun Xing, Xin Jiang, Chao-Feng Liu, Jing An, Feng-Chun Li, Tao Tao, Jin-Fa Jiang, Ying Yang, Yao-Rong Dong, Lei Zhang, Guang Fu, Ying Li, Shu-Wei Huang, Li-Ping Dou, Lan-Jun Sun, Ying-Qiang Zhao, Jie Li, Yun Xia, Fan Liu, Wen-Jin He, Jian-Cong Tan, Yang Lin, Ya-Bin Zhou, Jian-Fei Yang, Guo-Qing Ma, Hui-Jun Chen, He-Ping Liu, Zong-Wu Liu, Jian-Xiong Liu, Xiao-Jia Luo, Xiao-Hong Bin, Ya-Nan Yu, Hai-Xia Dang, Bing Li, Fei Teng, Wang-Min Qiao, Xiao-Long Zhu, Bing-Wei Chen, Qi-Guang Chen, Chun-Ti Shen, Yong-Yan Wang, Yun-Dai Chen, Zhong Wang
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-10 (2021)
Signal Transduction and Targeted Therapy
Signal Transduction and Targeted Therapy
It’s a challenge for detecting the therapeutic targets of a polypharmacological drug from variations in the responsed networks in the differentiated populations with complex diseases, as stable coronary heart disease. Here, in an adaptive, 31-cente
Autor:
Chii-Shan Lin, Yee-Jen Wu, Chih-Fen Huang, Shin-Yi Lin, Hao-Cheng Kang, Fe-Lin Lin Wu, Yi-Wen Chen, Chia-Wei Wu, Pin-Zi Chen, Li-Jiuan Shen, Yen-Ming Huang
Publikováno v:
Postgraduate Medicine. 133:964-973
Objective: The study aimed to evaluate the improvement of patient knowledge of warfarin use, satisfaction with pharmacists, and the quality of international normalized ratio (INR) control after the implementation of an anticoagulant clinic (ACC) serv
Publikováno v:
Thoracic Cancer, Vol 12, Iss 16, Pp 2233-2240 (2021)
Thoracic Cancer
Thoracic Cancer
Background Previous studies have demonstrated the combination of epidermal growth factor receptor (EGFR)‐tyrosine kinase inhibitors (TKIs) and other antitumor agents may delay drug resistance. In this study, we retrospectively reviewed the efficacy
Autor:
Guangshun Wang, Zhao-nan Sun, Hongming Ma, Lin-Lin Ji, Zi‐yi Chen, Chun-Yang Wang, Fanjie Meng, Zhouyong Gao, Fu-kai Feng, Zhi‐Na Wang, Nan Zhang, Wencheng Zhang, Bo Yang
Publikováno v:
Thoracic Cancer
Thoracic Cancer, Vol 12, Iss 18, Pp 2439-2448 (2021)
Thoracic Cancer, Vol 12, Iss 18, Pp 2439-2448 (2021)
Purpose The objective of our study was to investigate the epidemiologic characteristics and prognostic factors in patients with pulmonary acinar cell carcinoma (PACC). Methods PACC patients diagnosed between 1975 and 2016 were identified from the Sur
Autor:
Luoying Xie, Shudi Chen, Jing Hong, Xiuming Jin, Wei Chen, Bei Rong, Yun Feng, Xiaodan Huang, Jinyang Li, Wenjing Song, Lin Lin, Yu Cheng, Xiaoming Yan
Publikováno v:
BMC Ophthalmology. 22
Background This study was performed to investigate the association between symptoms and signs in patients with meibomian gland dysfunction (MGD). Methods Data were obtained from 122 MGD patients who were recruited for intense pulsed light therapy fro
Autor:
Jin Long Huang, Huai Wen Liang, Fa Po Chung, Wen Yu Lin, Chia Te Liao, Hung Yu Chang, Po Lin Lin, Wei Ru Chiou, Chien Yi Hsu, Ying Hsiang Lee
Publikováno v:
ESC Heart Failure
ESC Heart Failure, Vol 8, Iss 5, Pp 4199-4210 (2021)
ESC Heart Failure, Vol 8, Iss 5, Pp 4199-4210 (2021)
Aims Ivabradine has been used in patients who have chronic heart failure (HF) with reduced ejection fraction (HFrEF) and concomitant sinus heart rate ≥70 bpm. This administration for acute HFrEF remains a concern. This study used a real‐world mul